Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dendritic cell activation via paracrine cytokine signaling refers to the process by which DCs receive activation and maturation cues from cytokines secreted by neighboring cells (e.g., infected/stressed cells, innate immune cells), in addition to pathogen-sensing signals such as TLR agonists. At the molecular level, DC activation and maturation involve engagement of pattern-recognition receptors (notably TLRs) and cytokine receptors, which converge on key pathways including MAPK, NF-κB, and IRF, leading to upregulation of costimulatory molecules (CD40, CD80, CD86), enhanced antigen presentation (MHC), DC survival signals, and secretion of cytokines such as IL-12p70, IFN-α/β, and IL-10 that shape T cell polarization.[1][2][4] NF-κB signaling is closely linked with DC maturation, while ERK signaling contributes to survival during activation; these facets can be experimentally separable during LPS-induced activation.[1] The activation state and timing of maturation profoundly influence downstream T cell responses; for example, shorter ex vivo maturation intervals can enhance subsequent IL-12p70 production and T cell priming, informing DC vaccine design.[2] Functionally, activated DCs drive antigen-specific CD4+ and CD8+ T cell responses via antigen presentation and costimulatory and cytokine cues, impacting immunity against infections and tumors as well as autoimmune pathogenesis.[3][4][5]
Costimulation blockade (inhibiting CD28–B7 or LFA-3–CD2 to reduce DC-driven T cell activation); TLR pathway agonism to promote DC maturation and cytokine production via MAPK, NF-κB, and IRFs; Modulation of JAK/STAT signaling in cytokine pathways influencing DC activation state (conceptual link within cytokine signaling to DCs)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic cell activation via paracrine cytokine signaling.